Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Arq Gastroenterol ; 61: e23153, 2024.
Article in English | MEDLINE | ID: mdl-38451672

ABSTRACT

BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed worldwide, often resulting in their overuse. Consequently, it is essential to identify the likely causes of this overuse to facilitate their appropriate prescription. OBJECTIVE: This study aims to assess physician prescribing patterns, their knowledge of PPIs, and factors affecting their knowledge. METHODS: An online survey was conducted among Latin American and Spanish physicians, collecting the following data: professional information, patterns of PPI usage, familiarity with published evidence, and the management approach in three hypothetical case-scenarios. Participant knowledge was categorized as sufficient or insufficient based on the results of the case scenarios. Subsequently, subgroup analysis was performed based on physician training level, years in practice, specialty, and time since the last PPI literature review. RESULTS: A total of 371 physicians participated in the survey. Thirty-eight percent frequently prescribe PPIs, primarily for prophylactic purposes (57.9%). Eighty percent were unfamiliar with PPI deprescribing strategies, and 54.4% rarely reviewed the ongoing indication of patients taking a PPI. Sixty-four percent demonstrated sufficient knowledge in the case-scenarios. A significant association was observed between specialty type (medical vs surgical: 69.4% vs 46.8%, P<0.001), the timing of the PPI indication literature review (<5 years vs >5 years: 71.4% vs 58.7%, P=0.010), and sufficient knowledge. CONCLUSION: While most participants prescribed PPIs regularly and for prophylaxis purposes, the majority were unfamiliar with deprescribing strategies and rarely reviewed ongoing indications. Sufficient knowledge is correlated with recent literature reviews and medical specialty affiliation. BACKGROUND: • The study aims to evaluate physician prescribing patterns, assess their knowledge of proton pump inhibitors, and identify factors influencing their knowledge. BACKGROUND: • An online survey of Latin American and Spanish physicians assessed proton pump inhibitor usage patterns and case-scenario responses, categorizing knowledge, and conducting subgroup analysis based on training, experience, specialty, and literature review timing. BACKGROUND: • Thirty-eight percent of surveyed physicians commonly prescribed proton pump inhibitors, and among them, 80% were unfamiliar with deprescribing strategies, with 54.4% rarely reviewing ongoing indications. BACKGROUND: • Sufficient knowledge was correlated with recent literature reviews and medical specialty affiliations.


Subject(s)
Physicians , Proton Pump Inhibitors , Humans , Practice Patterns, Physicians' , Prescriptions , Proton Pump Inhibitors/therapeutic use
2.
Arq. gastroenterol ; 61: e23153, 2024. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1533820

ABSTRACT

ABSTRACT Background: Proton pump inhibitors (PPIs) are widely prescribed worldwide, often resulting in their overuse. Consequently, it is essential to identify the likely causes of this overuse to facilitate their appropriate prescription. Objective: This study aims to assess physician prescribing patterns, their knowledge of PPIs, and factors affecting their knowledge. Methods: An online survey was conducted among Latin American and Spanish physicians, collecting the following data: professional information, patterns of PPI usage, familiarity with published evidence, and the management approach in three hypothetical case-scenarios. Participant knowledge was categorized as sufficient or insufficient based on the results of the case scenarios. Subsequently, subgroup analysis was performed based on physician training level, years in practice, specialty, and time since the last PPI literature review. Results: A total of 371 physicians participated in the survey. Thirty-eight percent frequently prescribe PPIs, primarily for prophylactic purposes (57.9%). Eighty percent were unfamiliar with PPI deprescribing strategies, and 54.4% rarely reviewed the ongoing indication of patients taking a PPI. Sixty-four percent demonstrated sufficient knowledge in the case-scenarios. A significant association was observed between specialty type (medical vs surgical: 69.4% vs 46.8%, P<0.001), the timing of the PPI indication literature review (<5 years vs >5 years: 71.4% vs 58.7%, P=0.010), and sufficient knowledge. Conclusion: While most participants prescribed PPIs regularly and for prophylaxis purposes, the majority were unfamiliar with deprescribing strategies and rarely reviewed ongoing indications. Sufficient knowledge is correlated with recent literature reviews and medical specialty affiliation.


RESUMO Contexto: Os inibidores da bomba de prótons (IBPs) são amplamente prescritos em todo o mundo, muitas vezes resultando em seu uso excessivo. Consequentemente, é essencial identificar as prováveis causas desse uso excessivo para facilitar sua prescrição adequada. Objetivo: Este estudo tem como objetivo avaliar o padrão de prescrição dos médicos, seu conhecimento sobre IBPs e fatores que afetam seu conhecimento. Métodos: Uma pesquisa on-line foi conduzida entre médicos latino-americanos e espanhóis, coletando os seguintes dados: informações profissionais, padrões de uso de IBP, familiaridade com evidências publicadas e abordagem de manejo em três casos-cenários hipotéticos. O conhecimento dos participantes foi categorizado em suficiente ou insuficiente com base nos resultados dos cenários de caso. Posteriormente, a análise de subgrupos foi realizada com base no nível de formação do médico, anos de prática, especialidade e tempo desde a última revisão da literatura dos IBPs. Resultados: Um total de 371 médicos participaram da pesquisa. Trinta e oito por cento prescrevem frequentemente IBP, principalmente para fins profiláticos (57,9%). Oitenta por cento não estavam familiarizados com as estratégias de prescrição de IBP, e 54,4% raramente revisaram a indicação contínua de pacientes em uso de IBP. Sessenta e quatro por cento demonstraram conhecimento suficiente nos cenários-caso. Observou-se associação significativa entre o tipo de especialidade (médica vs cirúrgica: 69,4% vs 46,8%, P<0,001), o momento da revisão da literatura de indicação do IBP (<5 anos vs >5 anos: 71,4% vs 58,7%, P=0,010) e conhecimento suficiente. Conclusão: Embora a maioria dos participantes prescrevesse IBPs regularmente e para fins de profilaxia, no entanto, não estava familiarizada com estratégias de prescrição e raramente revisava as indicações em andamento. O conhecimento suficiente está correlacionado com revisões recentes da literatura e afiliação à especialidade médica.

3.
J Innate Immun ; 15(1): 517-530, 2023.
Article in English | MEDLINE | ID: mdl-37040733

ABSTRACT

Toll-like receptor 7 (TLR7) is an endosomal pathogen-associated molecular pattern (PAMP) receptor that senses single-stranded RNA (ssRNA) and whose engagement results in the production of type I IFN and pro-inflammatory cytokines upon viral exposure. Recent genetic studies have established that a dysfunctional TLR7-initiated signaling is directly linked to the development of inflammatory responses. We present evidence that TLR7 is preferentially expressed by monocyte-derived macrophages generated in the presence of M-CSF (M-MØ). We now show that TLR7 activation in M-MØ triggers a weak MAPK, NFκB, and STAT1 activation and results in low production of type I IFN. Of note, TLR7 engagement reprograms MAFB+ M-MØ towards a pro-inflammatory transcriptional profile characterized by the expression of neutrophil-attracting chemokines (CXCL1-3, CXCL5, CXCL8), whose expression is dependent on the transcription factors MAFB and AhR. Moreover, TLR7-activated M-MØ display enhanced pro-inflammatory responses and a stronger production of neutrophil-attracting chemokines upon secondary stimulation. As aberrant TLR7 signaling and enhanced pulmonary neutrophil/lymphocyte ratio associate with impaired resolution of virus-induced inflammatory responses, these results suggest that targeting macrophage TLR7 might be a therapeutic strategy for viral infections where monocyte-derived macrophages exhibit a pathogenic role.


Subject(s)
Monocytes , Toll-Like Receptor 7 , Humans , Toll-Like Receptor 7/metabolism , Monocytes/metabolism , Macrophage Colony-Stimulating Factor/metabolism , Neutrophil Infiltration , Cytokines/metabolism , Macrophages/metabolism , Chemokines/metabolism
4.
Cell Mol Life Sci ; 80(4): 96, 2023 Mar 17.
Article in English | MEDLINE | ID: mdl-36930354

ABSTRACT

Monocyte-derived macrophages contribute to pathogenesis in inflammatory diseases and their effector functions greatly depend on the prevailing extracellular milieu. Whereas M-CSF primes macrophages for acquisition of an anti-inflammatory profile, GM-CSF drives the generation of T cell-stimulatory and pro-inflammatory macrophages. Liver X Receptors (LXRα and LXRß) are nuclear receptors that control cholesterol metabolism and regulate differentiation of tissue-resident macrophages. Macrophages from rheumatoid arthritis and other inflammatory pathologies exhibit an enriched LXR pathway, and recent reports have shown that LXR activation raises pro-inflammatory effects and impairs the acquisition of the anti-Inflammatory profile of M-CSF-dependent monocyte-derived macrophages (M-MØ). We now report that LXR inhibition prompts the acquisition of an anti-inflammatory gene and functional profile of macrophages generated within a pathological environment (synovial fluid from Rheumatoid Arthritis patients) as well as during the GM-CSF-dependent differentiation of human monocyte-derived macrophages (GM-MØ). Mechanistically, inhibition of LXR results in macrophages with higher expression of the v-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homolog B (MAFB) transcription factor, which governs the macrophage anti-inflammatory profile, as well as over-expression of MAFB-regulated genes. Indeed, gene silencing experiments on human macrophages evidenced that MAFB is required for the LXR inhibitor to enhance the anti-inflammatory nature of human macrophages. As a whole, our results demonstrate that LXR inhibition prompts the acquisition of an anti-inflammatory transcriptional and functional profile of human macrophages in a MAFB-dependent manner, and propose the use of LXR antagonists as potential therapeutic alternatives in macrophage re-programming strategies during inflammatory responses.


Subject(s)
Arthritis, Rheumatoid , Granulocyte-Macrophage Colony-Stimulating Factor , Humans , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Macrophage Colony-Stimulating Factor/genetics , Up-Regulation , Macrophages/metabolism , Arthritis, Rheumatoid/pathology , Anti-Inflammatory Agents/metabolism , Liver X Receptors/genetics , Liver X Receptors/metabolism , MafB Transcription Factor/genetics , MafB Transcription Factor/metabolism
5.
J Clin Immunol ; 42(5): 1093-1105, 2022 07.
Article in English | MEDLINE | ID: mdl-35486340

ABSTRACT

Common variable immunodeficiency disorders (CVID), the most common primary immune deficiency, includes heterogeneous syndromes characterized by hypogammaglobulinemia and impaired antibody responses. CVID patients frequently suffer from recurrent infections and inflammatory conditions. Currently, immunoglobulin replacement therapy (IgRT) is the first-line treatment to prevent infections and aminorate immune alterations in CVID patients. Intravenous Immunoglobulin (IVIg), a preparation of highly purified poly-specific IgG, is used for treatment of immunodeficiencies as well as for autoimmune and inflammatory disorders, as IVIg exerts immunoregulatory and anti-inflammatory actions on innate and adaptive immune cells. To determine the mechanism of action of IVIg in CVID in vivo, we determined the effect of IVIg infusion on the transcriptome of peripheral blood mononuclear cells from CVID patients, and found that peripheral blood monocytes are primary targets of IVIg in vivo, and that IVIg triggers the acquisition of an anti-inflammatory gene profile in human monocytes. Moreover, IVIg altered the relative proportions of peripheral blood monocyte subsets and enhanced the proportion of CD14+ cells with a transcriptional, phenotypic, and functional profile that resembles that of monocytic myeloid-derived suppressor cells (MDSC). Therefore, our results indicate that CD14 + MDSC-like cells might contribute to the immunoregulatory effects of IVIg in CVID and other inflammatory disorders.


Subject(s)
Common Variable Immunodeficiency , Myeloid-Derived Suppressor Cells , Common Variable Immunodeficiency/drug therapy , Humans , Immunoglobulins, Intravenous , Leukocytes, Mononuclear , Monocytes
6.
Front Immunol ; 13: 835478, 2022.
Article in English | MEDLINE | ID: mdl-35280993

ABSTRACT

Liver X Receptors (LXR) control cholesterol metabolism and exert anti-inflammatory actions but their contribution to human macrophage polarization remains unclear. The LXR pathway is enriched in pro-inflammatory macrophages from rheumatoid arthritis as well as in tumors-associated macrophages from human tumors. We now report that LXR activation inhibits the anti-inflammatory gene and functional profile of M-CSF-dependent human macrophages, and prompts the acquisition of a pro-inflammatory gene signature, with both effects being blocked by an LXR inverse agonist. Mechanistically, the LXR-stimulated macrophage polarization shift correlates with diminished expression of MAFB and MAF, which govern the macrophage anti-inflammatory profile, and with enhanced release of activin A. Indeed, LXR activation impaired macrophage polarization in response to tumor-derived ascitic fluids, as well as the expression of MAF- and MAFB-dependent genes. Our results demonstrate that LXR activation limits the anti-inflammatory human macrophage polarization and prompts the acquisition of an inflammatory transcriptional and functional profile.


Subject(s)
Macrophage Colony-Stimulating Factor , Macrophages , Anti-Inflammatory Agents/metabolism , Anti-Inflammatory Agents/pharmacology , Cells, Cultured , Humans , Liver X Receptors/genetics , Liver X Receptors/metabolism , Macrophage Colony-Stimulating Factor/metabolism , Macrophages/metabolism
7.
Rev. inf. cient ; 100(3): e3457, 2021.
Article in Spanish | LILACS, CUMED | ID: biblio-1289639

ABSTRACT

RESUMEN Introducción: la educación a distancia es un sistema de enseñanza-aprendizaje que se desarrolla parcial o totalmente a través de las Tecnologías de la Información y la Comunicación, bajo un esquema bidireccional entre profesor y alumnos. Este sistema sustituye el modelo de interacción personal en el aula por uno de tutoría que responsabiliza al estudiante de su propia formación. Objetivo: Diseñar un sistema de acciones para la implementación de la educación a distancia en la carrera Sistemas de Información en Salud. Método: Para la realización de este trabajo se llevó a cabo una investigación aplicada, descriptiva, con un enfoque dialéctico materialista en la carrera Sistemas de Información en Salud de la Facultad de Ciencias Médicas "Dr. Ernesto Che Guevara de la Serna" de Pinar del Río; como métodos de nivel teórico se utilizó el histórico-lógico; del nivel empírico la revisión documental y la observación participativa. Resultados: Se reflejaron los resultados a través de un análisis crítico del proceso de enseñanza y aprendizaje a través de la educación a distancia de la carrera Sistemas de Información en Salud permitiendo el diseño de un sistema de acciones. Conclusiones: Se constata la existencia de dificultades en la preparación teórica, pedagógica y metodológica por parte de los profesores y tutores, así como cognitiva de los estudiantes, en relación con dicho proceso.


ABSTRACT Introduction: Distance education is a teaching - learning system, with partial or total characteristics, which is developed through information and communication technologies, using a bidirectional method between teachers and students. This system substitutes the traditional method used ( personal interaction in the classroom), for a tutoring one in which the students are responsible for their own training process. Objective: To design a system of actions to implement the distance education in the career of Health Information System. Method: To perform this work, an applied and descriptive research with a dialectical materialist approach was carried out in the career - Health Information Systems at the Facultad de Ciencias Médicas "Dr. Ernesto Che Guevara de la Serna", Pinar del Rio. The historical-logical method was used as theoretical level techniques and also as empirical level methods, documentary review and participatory observation were used too. Results: The outcomes achieved through a critical analysis of teaching - learning process and the distance education, allowed to design a system of actions to be implemented in the career - Health Information Systems. Conclusions: Many difficulties found have reveled lack of theoretical, pedagogical and methodological preparation on teachers and tutors, as well as lack of cognitive preparation of students concerning this process.


RESUMO Introdução: A educação a distancia é um sistema de enseñanza-aprendizaje que se desarrolla parcial ou totalmente a través de las Tecnologías de la Información y la Comunicación, bajo un esquema bidireccional entre profesor y alumnos. Este sistema sustenta o modelo de interação pessoal na aula por um de tutoria que responsabiliza o estudiante de sua formação. Objetivo: Distribuir um sistema de acionamento para a implementação da educação à distância na carrera Sistemas de Informação e Saúde. Método: Para a realização de este trabalho se llevó um cabo de uma investigação aplicada, descritiva, com um enfoque dialéctico materialista na carrera Sistemas de Informação em Saúde da Facultad de Ciencias Médicas "Dr. Ernesto Che Guevara de la Serna" de Pinar del Río; como métodos de nivel teórico se utilizó el histórico-lógico; del nivel empírico la revisión documental y la observación participativa. Resultados: Se reflejaron los resultados a través de uma análise crítica del processo de enseñanza y aprendizaje a través de la educación a distancia de la carrera Sistemas de Informação em Salud permitiendo o projeto de um sistema de acciones. Conclusiones: Se constata la existencia de dificultades en la preparación teórica, pedagógica y metodológica por parte de los profesores y tutores, así como cognitiva de los estudiantes, en relación con dicho proceso.


Subject(s)
Education, Distance/methods , Professional Training , Health Information Systems
8.
Intern Emerg Med ; 16(5): 1289-1295, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33400159

ABSTRACT

To assess the impact of a rapid diagnostic system based on nucleic acid amplification techniques (FilmArray ME) on the diagnosis and treatment of patients with meningitis or encephalitis admitted to our emergency department. Between November 2016, and June 2019 we studied 79 samples of cerebrospinal fluid from patients admitted to our emergency department with suspected diagnoses of meningitis or encephalitis. FilmArray ME panel was used routinely in addition to conventional laboratory methods for the identification of microorganisms in cerebrospinal fluid samples (CSF). A total of 46 (58%) patients had clinical and CSF results suggestive of meningitis or encephalitis, and 24 (30%) had a confirmed microbiological diagnosis. Patients' mean age was 41 years (range 2 months to 90 years) and 56% were male. Four patients had been partially treated with antibiotics. FilmArray ME identified 23 cases (1 fungal, 11 bacterial, and 11 viral). Gram staining showed microorganisms in 5 cases (1 fungal, 4 bacterial), and conventional microbiology cultures identified 8 cases (1 fungal and 7 bacterial). The time difference (95% confidence interval) between FilmArray ME and cerebrospinal fluid culture results was 3.2 days (95% CI 2.7-3.7; P < 0.001). FilmArray ME results induced modifications in antimicrobial treatment in 27 (59%) patients. The FilmArray ME panel provided a fast and reliable result in a large proportion of patients, even in those patients with culture-negative bacterial meningitis. Use of FilmArray ME can contribute to antimicrobial stewardship.


Subject(s)
Encephalitis/diagnosis , Meningitis/diagnosis , Time Factors , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cohort Studies , Emergency Service, Hospital/organization & administration , Emergency Service, Hospital/statistics & numerical data , Encephalitis/cerebrospinal fluid , Female , Humans , Infant , Male , Meningitis/cerebrospinal fluid , Middle Aged , Retrospective Studies , Sensitivity and Specificity , Spain , Statistics, Nonparametric
9.
Eur J Immunol ; 51(4): 824-834, 2021 04.
Article in English | MEDLINE | ID: mdl-33169838

ABSTRACT

CD28 expression is generally considered to be T lymphocyte specific. We have previously shown CD28 mRNA expression in M-CSF-dependent anti-inflammatory monocyte-derived macrophages (M-MØ), and now demonstrate that CD28 cell surface expression is higher in M-MØ than in GM-CSF-dependent macrophages, and that macrophage CD28 expression is regulated by MAFB and activin A. In vivo, CD28 was found in tumor-associated macrophages and, to a lower extent, in pro-inflammatory synovial fluid macrophages from rheumatoid arthritis patients. Analysis of mouse macrophages confirmed Cd28 expression in bone-marrow derived M-MØ. Indeed, anti-CD28 antibodies triggered ERK1/2 phosphorylation in mouse M-MØ. At the functional level, Cd28KO M-MØ exhibited a significantly higher capacity to activate the OVA-specific proliferation of OT-II CD4+ T cells than WT M-MØ, as well as enhanced LPS-induced IL-6 production. Besides, the Cd28KO M-MØ transcriptome was significantly different from WT M-MØ regarding the expression IFN response, inflammatory response, and TGF-ß signaling related gene sets. Therefore, defective CD28 expression in mouse macrophages associates to changes in gene expression profile, what might contribute to the altered functionality displayed by Cd28KO M-MØ. Thus, CD28 expression appears as a hallmark of anti-inflammatory macrophages and might be a target for immunotherapy.


Subject(s)
CD28 Antigens/immunology , Inflammation/immunology , Lymphocyte Activation/immunology , Macrophages/immunology , T-Lymphocytes/immunology , Activins/genetics , Activins/immunology , Activins/metabolism , Animals , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/metabolism , CD28 Antigens/genetics , CD28 Antigens/metabolism , Cells, Cultured , Gene Expression/immunology , Gene Expression Profiling/methods , Humans , Inflammation/genetics , Inflammation/metabolism , Lymphocyte Activation/genetics , Macrophages/metabolism , MafB Transcription Factor/genetics , MafB Transcription Factor/immunology , MafB Transcription Factor/metabolism , Mice, Inbred C57BL , Mice, Knockout , Signal Transduction/genetics , Signal Transduction/immunology , T-Lymphocytes/cytology , T-Lymphocytes/metabolism
10.
J Immunol ; 204(10): 2808-2817, 2020 05 15.
Article in English | MEDLINE | ID: mdl-32253244

ABSTRACT

Macrophages can either promote or resolve inflammatory responses, and their polarization state is modulated by peripheral serotonin (5-hydroxytryptamine [5-HT]). In fact, pro- and anti-inflammatory macrophages differ in the expression of serotonin receptors, with 5-HT2B and 5-HT7 expression restricted to M-CSF-primed monocyte-derived macrophages (M-MØ). 5-HT7 drives the acquisition of profibrotic and anti-inflammatory functions in M-MØ, whereas 5-HT2B prevents the degeneration of spinal cord mononuclear phagocytes and modulates motility of murine microglial processes. Because 5-HT2B mediates clinically relevant 5-HT-related pathologies (valvular heart disease, pulmonary arterial hypertension) and is an off target of anesthetics, antiparkinsonian drugs, and selective serotonin reuptake inhibitors, we sought to determine the transcriptional consequences of 5-HT2B engagement in human macrophages, for which 5-HT2B signaling remains unknown. Assessment of the effects of specific agonists and antagonist revealed that 5-HT2B engagement modifies the cytokine and gene signature of anti-inflammatory M-MØ, upregulates the expression of aryl hydrocarbon receptor (AhR) target genes, and stimulates the transcriptional activation of AhR. Moreover, we found that 5-HT dose dependently upregulates the expression of AhR target genes in M-MØ and that the 5-HT-mediated activation of AhR is 5-HT2B dependent because it is abrogated by the 5-HT2B-specific antagonist SB204741. Altogether, our results demonstrate the existence of a functional 5-HT/5-HT2B/AhR axis in human macrophages and indicate that 5-HT potentiates the activity of a transcription factor (AhR) that regulates immune responses and the biological responses to xenobiotics.


Subject(s)
Macrophages/physiology , Microglia/physiology , Receptor, Serotonin, 5-HT2B/metabolism , Receptors, Aryl Hydrocarbon/metabolism , Serotonin/metabolism , Cell Differentiation , Cells, Cultured , Humans , Indoles/pharmacology , Phagocytosis , RNA, Small Interfering/genetics , Receptors, Aryl Hydrocarbon/genetics , Receptors, Serotonin/metabolism , Serotonin 5-HT2 Receptor Agonists/pharmacology , Signal Transduction , Thiophenes/pharmacology , Transcriptional Activation , Transcriptome
11.
Dermatol. argent ; 26(1): 2-10, 2020. ilus, tab
Article in Spanish | LILACS | ID: biblio-1146328

ABSTRACT

El síndrome de Sézary (SS) es una rara y agresiva variante leucémica del linfoma cutáneo de células T, de pronóstico ominoso. Se caracteriza por presentar la tríada eritrodermia, linfadenopatías y linfocitos T neoplásicos circulantes. El diagnóstico está dado por la clínica, el estudio histopatológico, la citometría de flujo y el reordenamiento genético del receptor del linfocito T. En esta revisión se analizan la presentación clínica, la histopatología, el diagnóstico y el pronóstico de este síndrome. (AU)


Sézary syndrome (SS) is a rare and aggressive leukemic cutaneous T-cell lymphoma with poor prognosis. Is characterized by a triad of erythroderma, lymphadenopathy and circulating neoplastic T cells. Diagnosis is made by clinical features, histopathology, flow cytometry and T-cell receptor gene rearrangements. In this review we will analyze clinical presentation, histopathology, diagnosis and prognosis of SS. (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Skin Neoplasms/diagnosis , Sezary Syndrome/diagnosis , Prognosis , Mycosis Fungoides/diagnosis , Dermatitis/diagnosis , Diagnosis, Differential
12.
PLoS One ; 14(12): e0226775, 2019.
Article in English | MEDLINE | ID: mdl-31869375

ABSTRACT

The cognitive-motor interference (CMI) produced by simultaneous performance of a cognitive and a motor task has been proposed as a marker of real-life impairment of people with Multiple Sclerosis (pwMS), yet there is no consensus on the dual task (DT) procedure. This study aimed to compare DT performance of pwMS and healthy controls (HC) under different instructions and to examine its association with neuropsychological and clinical variables. PwMS (N = 23; relapsing-remitting course) and HC (N = 24) completed the cognitive (Verbal Fluency) and motor (walking) tasks under three conditions: independently or as single task (ST), both tasks simultaneously at best capacity or double prioritization (DT-DP), and only the cognitive task at best capacity while walking at preferred speed or cognitive prioritization (DT-CP). Compared to HC, pwMS walked significantly slower and produced less correct words under all conditions. The distance walked by pwMS and HC significantly differed between conditions (DT-CP< DT-DP< ST). PwMS produced more words during ST respective to DT-DP and DT-CP, with no difference between both DT conditions. HC showed no differences in cognitive performance between conditions. Motor and cognitive dual-task costs (DTC) were similar between groups. Only in pwMS, the cognitive DTC of DT-DP was different from zero. CMI measures correlated with neuropsychological, symptomatic, physiological (cognitive event-related potentials) and clinical variables. These results suggest that cognitive performance while walking is impaired in pwMS, but not in HC. CMI over cognitive performance might be a potential early marker of cognitive decline in pwMS, which may be enhanced by the instruction to prioritize both tasks in DT.


Subject(s)
Multiple Sclerosis, Relapsing-Remitting/physiopathology , Adult , Cognition , Female , Humans , Male , Middle Aged , Multiple Sclerosis, Relapsing-Remitting/psychology , Psychomotor Performance , Task Performance and Analysis
13.
J Emerg Med ; 57(3): 290-298, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31405783

ABSTRACT

BACKGROUND: Information on the epidemiology and susceptibility patterns of main pathogens causing severe acute diarrhea may help to reduce inappropriate antimicrobial use in emergency departments. OBJECTIVES: We sought to investigate the micro-organisms causing severe acute diarrhea in patients requiring hospital admission by means of a commercial multiple polymerase chain reaction system. METHODS: Between November 2016 and October 2018 we studied 132 patients with acute diarrhea who required hospital admission at a 250-bed hospital in Spain. Demographic, clinical, analytical, and microbiological data were collected from the medical records. Stool samples were processed using a rapid commercial multiple polymerase chain reaction system (FilmArray Gastrointestinal Panel), stool culture, and standard microbiological procedures. RESULTS: The median age (range) of patients was 45.5 (0.1-92) years, and 50% were male; 46.2% presented with fever, 62.8% presented with vomiting, and 12.9% presented with rectal bleeding. At least 1 enteric pathogen was identified in 93 (70.4%) patients; 28 (21.2%) patients had >1 micro-organism. FilmArray Gastrointestinal Panel results were available in a median (range) of 1 (0-3) days. The micro-organisms most frequently identified were 24 cases of Campylobacter species, 20 cases of Clostridioides difficile producing toxin A or toxin B, 20 cases of Salmonella species, 12 cases of rotavirus, and 30 cases of different types of pathogenic Escherichia coli. Among the cases of C. difficile, 12 (60%) were community-acquired and 8 (40%) had an undetermined origin. CONCLUSION: The FilmArray Gastrointestinal Panel system provides fast and reliable results and could be useful to select the most appropriate antimicrobial based on local susceptibilities until the results of the cultures are available.


Subject(s)
Bacterial Infections/microbiology , Diarrhea/epidemiology , Acute Disease , Adolescent , Adult , Aged , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Child , DNA, Bacterial/analysis , Diarrhea/microbiology , Drug Resistance, Bacterial/drug effects , Feces/microbiology , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction , Retrospective Studies , Young Adult
15.
Dermatol. pediátr. latinoam. (En línea) ; 14(1): 12-21, mar. 2019. tab, ilus
Article in Spanish | LILACS | ID: biblio-1005430

ABSTRACT

La incontinencia pigmenti es una genodermatosis poco frecuente, de herencia dominante ligada al X, que se caracteriza por la presencia de lesiones cutáneas típicas que pueden asociarse con afectación de otros tejidos derivados del neuroectodermo. Es una enfermedad potencialmente grave, que requiere un diagnóstico precoz y un seguimiento multidisciplinario de por vida.Se presenta el caso de un paciente de sexo femenino de 6 días de vida con diagnóstico clínico y anatomopatológico de incontinencia pigmenti


Incontinentiapigmenti is a rare, X-linked dominantgenodermatosis, characterized by the presence of typical skin lesions that may be associated with involvement of other tissues derived from neuroectoderm. It is a potentially serious disease that requires early diagnosis and a multidisciplinary life-long follow up.Wereport the case of a 6 day old femalewith a clinical and anatomopathological diagnosis of incontinenciapigmenti.


Subject(s)
Humans , Incontinentia Pigmenti , Leg
16.
Front Immunol ; 9: 1328, 2018.
Article in English | MEDLINE | ID: mdl-29951065

ABSTRACT

Lenalidomide is an analog of thalidomide, with potent anticancer activity demonstrated in several hematological malignancies. It has immunomodulatory properties, being able to enhance the activation of different types of immune cells, which results in antitumor activities. Dendritic cells (DCs) are pivotal in the immune response, and different immunotherapeutic approaches targeting these cells are being developed. Since little is known about the effect of lenalidomide on DCs, the goal of the present work was to investigate the phenotype and function of human monocyte-derived DCs differentiated in the presence of lenalidomide (L-DCs). Our results showed that L-DCs display a unique phenotype, with increased cell surface expression of some maturation markers such as CD1d, CD83, CD86, and HLA-DR. This phenotype correlates with a lower expression of the E3 ubiquitin-ligase MARCH-I in L-DCs, upregulating the cell surface expression of CD86 and HLA-DR. In addition, immature L-DCs express higher amounts of DC-SIGN on the cell surface than control immature DCs. After LPS stimulation, production of IL-6 and TNF-α was severely decreased, whereas IL-12 and IL-10 secretion was dramatically upregulated in L-DCs, compared to that in the controls. Functionally, L-DCs are more effectively recognized by NKT cells in cytotoxicity experiments. Furthermore, L-DCs display higher opsonin-independent antigen uptake capability than control DCs. Mixed lymphocyte reaction experiments showed that L-DCs could stimulate naïve CD4 T-cells, polarizing them toward a predominant Th1 phenotype. In summary, DCs derived from monocytes in the presence of lenalidomide present a semi-mature phenotype, increased phagocytic capacity, reduced production of proinflammatory cytokines, and the ability to polarize T-cells toward predominant Th1-type responses; these are qualities that might be useful in the development of new immunotherapeutic treatments.

17.
Front Immunol ; 9: 31, 2018.
Article in English | MEDLINE | ID: mdl-29434585

ABSTRACT

GM-CSF promotes the functional maturation of lung alveolar macrophages (A-MØ), whose differentiation is dependent on the peroxisome proliferator-activated receptor gamma (PPARγ) transcription factor. In fact, blockade of GM-CSF-initiated signaling or deletion of the PPARγ-encoding gene PPARG leads to functionally defective A-MØ and the onset of pulmonary alveolar proteinosis. In vitro, macrophages generated in the presence of GM-CSF display potent proinflammatory, immunogenic and tumor growth-limiting activities. Since GM-CSF upregulates PPARγ expression, we hypothesized that PPARγ might contribute to the gene signature and functional profile of human GM-CSF-conditioned macrophages. To verify this hypothesis, PPARγ expression and activity was assessed in human monocyte-derived macrophages generated in the presence of GM-CSF [proinflammatory GM-CSF-conditioned human monocyte-derived macrophages (GM-MØ)] or M-CSF (anti-inflammatory M-MØ), as well as in ex vivo isolated human A-MØ. GM-MØ showed higher PPARγ expression than M-MØ, and the expression of PPARγ in GM-MØ was found to largely depend on activin A. Ligand-induced activation of PPARγ also resulted in distinct transcriptional and functional outcomes in GM-MØ and M-MØ. Moreover, and in the absence of exogenous activating ligands, PPARγ knockdown significantly altered the GM-MØ transcriptome, causing a global upregulation of proinflammatory genes and significantly modulating the expression of genes involved in cell proliferation and migration. Similar effects were observed in ex vivo isolated human A-MØ, where PPARγ silencing led to enhanced expression of genes coding for growth factors and chemokines and downregulation of cell surface pathogen receptors. Therefore, PPARγ shapes the transcriptome of GM-CSF-dependent human macrophages (in vitro derived GM-MØ and ex vivo isolated A-MØ) in the absence of exogenous activating ligands, and its expression is primarily regulated by activin A. These results suggest that activin A, through enhancement of PPARγ expression, help macrophages to switch from a proinflammatory to an anti-inflammatory polarization state, thus contributing to limit tissue damage and restore homeostasis.


Subject(s)
Activins/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Inflammation/immunology , Macrophages, Alveolar/cytology , Macrophages, Alveolar/immunology , PPAR gamma/metabolism , Animals , Cell Differentiation/immunology , Cell Line , Culture Media, Conditioned/pharmacology , Gene Expression Regulation , HEK293 Cells , Humans , Inflammation/pathology , Macrophages, Alveolar/metabolism , Mice , Mice, Inbred C57BL , PPAR gamma/genetics , RNA Interference , RNA, Small Interfering/genetics
18.
J Immunol ; 199(11): 3858-3869, 2017 12 01.
Article in English | MEDLINE | ID: mdl-29061766

ABSTRACT

Obesity is associated with low-grade inflammation and elevated levels of circulating saturated fatty acids, which trigger inflammatory responses by engaging pattern recognition receptors in macrophages. Because tissue homeostasis is maintained through an adequate balance of pro- and anti-inflammatory macrophages, we assessed the transcriptional and functional profile of M-CSF-dependent monocyte-derived human macrophages exposed to concentrations of saturated fatty acids found in obese individuals. We report that palmitate (C16:0, 200 µM) significantly modulates the macrophage gene signature, lowers the expression of transcription factors that positively regulate IL-10 expression (MAFB, AhR), and promotes a proinflammatory state whose acquisition requires JNK activation. Unlike LPS, palmitate exposure does not activate STAT1, and its transcriptional effects can be distinguished from those triggered by LPS, as both agents oppositely regulate the expression of CCL19 and TRIB3 Besides, palmitate conditions macrophages for exacerbated proinflammatory responses (lower IL-10 and CCL2, higher TNF-α, IL-6, and IL-1ß) toward pathogenic stimuli, a process also mediated by JNK activation. All of these effects of palmitate are fatty acid specific because oleate (C18:1, 200 µM) does not modify the macrophage transcriptional and functional profiles. Therefore, pathologic palmitate concentrations promote the acquisition of a specific polarization state in human macrophages and condition macrophages for enhanced responses toward inflammatory stimuli, with both effects being dependent on JNK activation. Our results provide further insight into the macrophage contribution to obesity-associated inflammation.


Subject(s)
Inflammation/immunology , Macrophages/immunology , Obesity/immunology , Palmitates/immunology , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Differentiation , Cells, Cultured , Chemokine CCL19/genetics , Chemokine CCL19/metabolism , Cytokines/metabolism , Gene Expression Regulation , Humans , Inflammation Mediators/metabolism , MAP Kinase Kinase 4/metabolism , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Transcriptional Activation , Transcriptome
19.
Clin Immunol ; 181: 43-50, 2017 08.
Article in English | MEDLINE | ID: mdl-28578025

ABSTRACT

Delay in the diagnosis of multiple sclerosis (MS) stems from the lack of specific clinical and analytical markers to assist in the early diagnosis and prediction of progressive course. We propose a decision-tree model that better defines early at onset MS patients and those with the progressive form by analysing a 12-biomarkers panel in serum and CSF samples of patients with MS, other neurological diseases (OND) and healthy contols. Thus, patients at onset of neurological disease were first classified by serum IL-7 levels <141pg/ml (OR=6.51, p<0.001). Combination of IL-7 and CXCL10 indicated risk for a specific MS clinical form, where IL-7<141 and CXCL10<570pg/ml were associated with the highest risk for PP-MS (OR=22, p=0.01). Unexpectedly, both PP-MS and RR-MS patients shared significantly decreased prototypical biomarkers of inflammation and tissue regeneration in CSF than OND suggesting a defective intrinsic immune response playing a role at the beginning of the disease.


Subject(s)
Multiple Sclerosis, Chronic Progressive/diagnosis , Multiple Sclerosis, Relapsing-Remitting/diagnosis , Area Under Curve , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Case-Control Studies , Chemokine CCL11 , Chemokine CCL2 , Chemokine CCL4 , Chemokine CCL5 , Chemokine CXCL10/blood , Chemokine CXCL10/cerebrospinal fluid , Chemokine CXCL9/blood , Chemokine CXCL9/cerebrospinal fluid , Decision Trees , Dipeptidyl Peptidase 4/blood , Dipeptidyl Peptidase 4/cerebrospinal fluid , Early Diagnosis , Epidermal Growth Factor , Fibroblast Growth Factor 2/blood , Fibroblast Growth Factor 2/cerebrospinal fluid , Hepatocyte Growth Factor , Humans , Interleukin 1 Receptor Antagonist Protein/blood , Interleukin 1 Receptor Antagonist Protein/cerebrospinal fluid , Interleukin-7/blood , Interleukin-7/cerebrospinal fluid , Multiple Sclerosis, Chronic Progressive/blood , Multiple Sclerosis, Chronic Progressive/cerebrospinal fluid , Multiple Sclerosis, Relapsing-Remitting/blood , Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid , Multivariate Analysis , Nervous System Diseases/blood , Nervous System Diseases/cerebrospinal fluid , Nervous System Diseases/diagnosis , Prognosis , Risk Assessment
20.
J Alzheimers Dis ; 58(1): 185-192, 2017.
Article in English | MEDLINE | ID: mdl-28387673

ABSTRACT

BACKGROUND: Heparan sulfate proteoglycans (HSPGs) promote amyloid-ß peptide and tau fibrillization in Alzheimer's disease (AD) and provide resistance against proteolytic breakdown. Heparanase (HPSE) is the only enzyme that cleaves heparan sulfate (HS). Heparanase 2 (HPSE2) lacks HS-degrading activity, although it is able to interact with HS with high affinity. OBJECTIVE: To analyze HPSE and HPSE2 expressions at different stages of AD. METHODS: RT-PCR was used to analyze transcription levels of both heparanases at different stages of AD, and immunohistochemistry was performed to localize each one in different parts of the brain. RESULTS: Both proteins appeared overexpressed at different stages of AD. Immunohistochemistry indicated that the presence of the heparanases was related to AD pathology, with intracellular deposits found in degenerated neurons. At the extracellular level, HPSE was observed only in neuritic plaques with a fragmented core, while HPSE2 appeared in those with compact cores as well. CONCLUSION: Given the involvement of HSPGs in AD pathology, there would seem to be a relationship between the regulation of heparanase expression, the features of the disease, and a possible therapeutic alternative.


Subject(s)
Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Brain/enzymology , Glucuronidase/metabolism , Up-Regulation/physiology , Aged , Aged, 80 and over , Female , Glucuronidase/genetics , Humans , Male , Middle Aged , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL